| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048831358 |
| P356 | DOI | 10.1186/1471-2482-12-S1-S7 |
| P932 | PMC publication ID | 3499206 |
| P698 | PubMed publication ID | 23173843 |
| P50 | author | Filippo Drago | Q18355267 |
| Gaetano Bertino | Q30512640 | ||
| P2093 | author name string | Giulia Malaguarnera | |
| Michele Malaguarnera | |||
| Massimiliano Berretta | |||
| Velia D'Agata | |||
| Antonio Biondi | |||
| Francesco Basile | |||
| Marco Vacante | |||
| P2860 | cites work | Hepatocellular carcinoma | Q29615841 |
| Prognosis of hepatocellular carcinoma: the BCLC staging classification | Q29619984 | ||
| Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments | Q33382704 | ||
| Markers of bile duct tumors | Q34628852 | ||
| The clinical significance of thickened gastric folds found on upper gastrointestinal series | Q34781187 | ||
| Prognostic assessment and evaluation of the benefits of treatment | Q34977608 | ||
| Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. | Q37157400 | ||
| Natural heme oxygenase-1 inducers in hepatobiliary function | Q37318063 | ||
| Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report | Q37403355 | ||
| Primary hepatic carcinoid: a case report and literature review. | Q37488007 | ||
| Nutritional aspects in patient undergoing liver resection. | Q37954166 | ||
| Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma | Q37970902 | ||
| The role of diet in gastric cancer: still an open question | Q37971581 | ||
| Hepatocellualar carcinoma serum markers | Q38030776 | ||
| The neo-adjuvant treatment in gastrointestinal stromal tumor | Q42938481 | ||
| Serum Markers of Hepatocellular Carcinoma | Q59388191 | ||
| 'Neuroendocrine' differentiation in primary neoplasms of the liver | Q67914059 | ||
| "Neuroendocrine" differentiation in hepatocellular carcinomas (HCCs): immunohistochemical reactivity is related to distinct tumor cell types, but not to tumor grade | Q72768031 | ||
| Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies | Q77102007 | ||
| Primary neuroendocrine carcinoma of the liver: an autopsy case | Q77637700 | ||
| Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer | Q80841857 | ||
| [Plasma chromogranin-A (CgA)--a potential marker for diagnosis, monitoring and management of prostate cancer patients] | Q82440455 | ||
| Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patients | Q84573889 | ||
| Primary neuroendocrine tumor in the liver treated by hepatectomy: report of a case | Q85037398 | ||
| Primary hepatic neuroendocrine tumour requiring live donor liver transplantation: case report and concise review | Q95403868 | ||
| P304 | page(s) | S7 | |
| P577 | publication date | 2012-11-15 | |
| P1433 | published in | BMC Surgery | Q15754671 |
| P1476 | title | Elevated serum levels of Chromogranin A in hepatocellular carcinoma | |
| P478 | volume | 12 Suppl 1 |
| Q34993913 | Adult hepatic cavernous hemangioma with highly elevated α-fetoprotein: A case report and review of the literature |
| Q34036884 | Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas |
| Q26775011 | Chronic hepatitis C: This and the new era of treatment |
| Q26750646 | Hepatocellular carcinoma and the risk of occupational exposure |
| Q33895113 | Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies |
| Q34397639 | Increased serum mitochondrial creatine kinase activity as a risk for hepatocarcinogenesis in chronic hepatitis C patients |
| Q60310020 | NRAGE is a potential diagnostic biomarker of hepatocellular carcinoma |
| Q38397273 | Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review |
| Q38186654 | Rare benign tumors of the liver: still rare? |
| Q55465315 | Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions. |
| Q37706763 | Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications |
| Q35744895 | Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma |
| Q42906829 | Solitary hepatic lymphangioma: a one-case report |
| Q40661336 | Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis |
| Q38150875 | Systemic therapies in hepatocellular carcinoma: present and future |
| Q37165091 | The association between biliary tract inflammation and risk of digestive system cancers: A population-based cohort study |
| Q39535683 | The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies |
Search more.